Delfi gets $100m funding to develop liquid biopsy for early cancer detection
Delfi ito use the funding to expand its cancer research and machine learning capabilities. (Credit: Michal Jarmoluk from Pixabay.)
NS Medical Devices is using cookies
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X